| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/12/2013 | US8394369 Chondrocyte therapeutic delivery system |
| 03/12/2013 | CA2706661C Intermediates for the preparation of lipoxin a4 analogs |
| 03/12/2013 | CA2699568C Azaindoles |
| 03/12/2013 | CA2649286C 2-hydroxybenzoic acid derivatives for treating or preventing degenerative and inflammatory diseases |
| 03/12/2013 | CA2464111C Phosphonic acid compounds as inhibitors of serine proteases |
| 03/12/2013 | CA2464092C Electroprocessing in drug delivery and cell encapsulation |
| 03/12/2013 | CA2461714C Treatment of chronic joint inflammation |
| 03/07/2013 | WO2013033680A1 Bmp peptides & methods of use |
| 03/07/2013 | WO2013033602A2 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | WO2013033569A1 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | WO2013032527A1 Llp2a-bisphosphonate conjugates for osteoporosis treatment |
| 03/07/2013 | WO2013032096A1 Capric acid having inhibiting effect on osteoclast formation and pharmaceutical composition containing same |
| 03/07/2013 | WO2013032012A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013032011A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | WO2013031935A1 Stable pharmaceutical composition |
| 03/07/2013 | WO2013031831A1 Method for improving therapy for autoimmune diseases such as rheumatoid arthritis |
| 03/07/2013 | WO2013031620A1 Osteogenesis promoter and use thereof |
| 03/07/2013 | WO2013030669A2 Treatment of inflammatory disease or disorder and compositions therefor |
| 03/07/2013 | WO2013030362A1 Modulators of mir-323-3p for the prevention or treatment of rheumatoid arthritis |
| 03/07/2013 | WO2013030218A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | WO2013029479A1 Mycophenolic acid derivative and preparation method and use thereof |
| 03/07/2013 | WO2013029338A1 Novel compounds |
| 03/07/2013 | US20130059904 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 03/07/2013 | US20130059884 Inhibitor of the differentiation of t cells into th1 cells |
| 03/07/2013 | US20130059868 Treatment of gout |
| 03/07/2013 | US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 03/07/2013 | US20130059858 Benzofuranyl analogues as gpr119 modulators |
| 03/07/2013 | US20130059850 Aza-indole derivatives useful as modulators of faah |
| 03/07/2013 | US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| 03/07/2013 | US20130059846 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059828 Pharmaceutical composition |
| 03/07/2013 | US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs |
| 03/07/2013 | US20130059816 Compositions and methods for treatment of autoimmune and other disease |
| 03/07/2013 | US20130059811 Method for treating and preventing arthritis |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059800 Pyrrolobenzodiazepines used to treat proliferative diseases |
| 03/07/2013 | US20130059779 Stabilized Insulin-like Growth Factor Polypeptides |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059382 Biomedical materials for tissue engineering |
| 03/07/2013 | US20130059013 Injectable osteoinductive bone cements |
| 03/07/2013 | US20130059012 Methods for the Diagnosis, Control and Prophylaxis of Inflammation and Mitigation of Inflammatory Conditions in Felines |
| 03/07/2013 | US20130059011 Bioactive bone graft substitute |
| 03/07/2013 | US20130059005 Bupropion hydrobromide polymorphs |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058991 Matricryptic ecm peptides for tissue reconstruction |
| 03/07/2013 | US20130058980 Small molecule inhibitors of protein kinases |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058957 Dendritic cell immunoreceptor agonist |
| 03/07/2013 | US20130058917 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058892 Pyrimidinyl indole compounds |
| 03/07/2013 | US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 03/07/2013 | CA2847527A1 Bmp peptides & methods of use |
| 03/07/2013 | CA2847336A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847334A1 Glycosylated polypeptide and drug composition containing said polypeptide |
| 03/07/2013 | CA2847017A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | CA2846652A1 Heterocyclylamines as pi3k inhibitors |
| 03/06/2013 | EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/06/2013 | EP2565185A1 [5,6]heterocyclic compound |
| 03/06/2013 | EP2565182A1 Novel amide derivative and use thereof as medicine |
| 03/06/2013 | EP2564900A1 C-19 steroids for therapeutic uses |
| 03/06/2013 | EP2564866A2 Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | EP2564849A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 03/06/2013 | EP2564844A2 Composition for treating bone disease comprising a glyceollin as an active ingredient |
| 03/06/2013 | EP2563789A1 7-(1h-pyrazol-4-yl)-1,6-naphthyridine compounds as syk inhibitors |
| 03/06/2013 | EP2563768A2 Preparation of febuxostat |
| 03/06/2013 | EP2563406A1 Methods, compositions, and kits for the treatment of matrix mineralization disorders |
| 03/06/2013 | EP2563385A1 Methods of use of soluble cd24 for therapy of rheumatoid arthritis |
| 03/06/2013 | EP2563377A1 Treatment of cartilage resorption |
| 03/06/2013 | EP2563372A1 Prebiotic formulations and methods of use |
| 03/06/2013 | CN202761909U Ginger medicine hot push capsule |
| 03/06/2013 | CN102958532A Pharmaceutical composition using connective tissue growth factor |
| 03/06/2013 | CN102958521A Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 03/06/2013 | CN102958377A Stabilized active compound |
| 03/06/2013 | CN102952697A Stropanthus divericatus health care wine for fracture |
| 03/06/2013 | CN102952671A Anti-rheumatism Siberian cocklebur fruit health-care wine |
| 03/06/2013 | CN102952168A Estrogen derivative used as vasoinhibitor, as well as preparation method and medical application thereof |
| 03/06/2013 | CN102952105A Mycophenolic acid derivative, preparation method thereof and application thereof |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102949725A Injection medicine composition containing glucocorticoid and NOS (nitric oxide synthase) inhibitor |
| 03/06/2013 | CN102949722A Novel pharmaceutical composition based on p38 inhibitor and cell growth factor |
| 03/06/2013 | CN102949711A Novel difunctional enzyme for promoting growth and development of bones and targeting abnormal development of bones |
| 03/06/2013 | CN102949710A Pharmaceutical composition or healthcare product for increasing bone mineral density and preparation method of pharmaceutical composition or healthcare product |
| 03/06/2013 | CN102949691A Tincture health product for arthritis and preparation method thereof |
| 03/06/2013 | CN102949684A Medicine formula for treating rheumatoid arthritis |
| 03/06/2013 | CN102949683A Foot bathing liquid capable of warming pubic region |
| 03/06/2013 | CN102949680A Medicinal liquor for treating cervical spondylosis and preparation method thereof |
| 03/06/2013 | CN102949675A Traditional Chinese medicine for treating gout |
| 03/06/2013 | CN102949673A Traditional Chinese medicine composition used for treating rheumatic arthritis and preparation method thereof |
| 03/06/2013 | CN102949670A Traditional Chinese medicinal composite for treating protrusion of lumbar intervertebral disc |
| 03/06/2013 | CN102949653A Traditional Chinese medicine composition for treating scapulohumeral periarthritis |
| 03/06/2013 | CN102949651A Stasis-removing bonesetting powder |
| 03/06/2013 | CN102949648A Traditional Chinese medicine for treating traumatic injury |
| 03/06/2013 | CN102949646A Traditional Chinese medicine preparation for curing femoral head necrosis |
| 03/06/2013 | CN102949634A Traditional Chinese medicine for treating cervical spondylosis, lumbar disc herniation and scapulohumeral periarthritis and preparation method thereof |
| 03/06/2013 | CN102949620A Traditional Chinese medicine composition for treating paralysis |
| 03/06/2013 | CN102949618A Multifunctional diet tea |